Form EFFECT CITIUS ONCOLOGY, INC.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 2, 2026 |
| Accession Number: | 0001213900-26-018829 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dogecoin Price Prediction: Dogecoin Labs Unites Teams Behind 500,000-User Wallet as Remittix Earn Targets Up to 22% APY
- Best Crypto to Buy in October 2026? Tesla and SpaceX Hold 30,221 BTC as Remittix Plans to Cut Supply 20%
- Crypto Market News: Bitcoin Near $81,500 as $33M Remittix Prepares a 41-Currency PayFi Expansion
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
